Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
about
Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focusCurrent understanding of conventional outflow dysfunction in glaucomaProspects for lentiviral vector mediated prostaglandin F synthase gene delivery in monkey eyes in vivoCritical evaluation of latanoprostene bunod in the treatment of glaucomaEffects of Four Formulations of Prostaglandin Analogs on Eye Surface Cells. A Comparative StudyPharmaceutical intervention for myopia control.Analyzing live cellularity in the human trabecular meshworkLong-term effect of latanoprost/timolol fixed combination in patients with glaucoma or ocular hypertension: a prospective, observational, noninterventional study.Stanniocalcin-1 Is an Ocular Hypotensive Agent and a Downstream Effector Molecule That Is Necessary for the Intraocular Pressure-Lowering Effects of Latanoprost.Efficacy and safety of benzalkonium chloride-free fixed-dose combination of latanoprost and timolol in patients with open-angle glaucoma or ocular hypertension.Clinical utility and differential effects of prostaglandin analogs in the management of raised intraocular pressure and ocular hypertensionSphingolipids and ceramides of mouse aqueous humor: Comparative profiles from normotensive and hypertensive DBA/2J mice.[Effectiveness of selective laser trabeculoplasty in patients with insufficient control of intraocular pressure despite maximum tolerated medical therapy].A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertensionProstaglandin-induced cystoid macular edema following routine cataract extraction.Regulation of retinal proteome by topical antiglaucomatous eye drops in an inherited glaucoma rat modelEffects of prostaglandin analogues on aqueous humor outflow pathways.Targeted delivery of antiglaucoma drugs to the supraciliary space using microneedles.Thermal stability of bimatoprost, latanoprost, and travoprost under simulated daily use.Clinical options for the reduction of elevated intraocular pressureA cross-sectional survey of the association between bilateral topical prostaglandin analogue use and ocular adnexal featuresExcipients of preservative-free latanoprost induced inflammatory response and cytotoxicity in immortalized human HCE-2 corneal epithelial cells.The impact of timolol maleate on the ocular tolerability of fixed-combination glaucoma therapies.Glaucoma management: relative value and place in therapy of available drug treatments.Trans-conjunctival aqueous humor outflow in glaucomatous patients treated with prostaglandin analogues: an in vivo confocal microscopy study.Is There Any Role for the Choroid in Glaucoma?Expression profile of the matricellular protein osteopontin in primary open-angle glaucoma and the normal human eye.Fixed-combination treatments for intraocular hypertension in Chinese patients - focus on bimatoprost-timolol.Pharmacotherapy and Adherence Issues in Treating Elderly Patients with Glaucoma.Head-down posture induces PERG alterations in early glaucoma.Bimatoprost, latanoprost, and tafluprost induce differential expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases.Effects of Latanoprost and Bimatoprost on the Expression of Molecules Relevant to Ocular Inflow and Outflow PathwaysLong-term assessment of prostaglandin analogs and timolol fixed combinations vs prostaglandin analogs monotherapyFormulation to target delivery to the ciliary body and choroid via the suprachoroidal space of the eye using microneedlesTopical prostaglandin analogues and conjunctival inflammation in uveitic glaucomaBilateral serous detachment associated with latanoprost/timolol fixed combination use: a report of one phakic case.Effect of topical latanoprost 0.005% on intraocular pressure and pupil diameter in normal and glaucomatous catsComparative phospholipid profiles of control and glaucomatous human trabecular meshworkEffect of benzalkonium chloride-free latanoprost ophthalmic solution on ocular surface in patients with glaucoma.Imaging the effects of prostaglandin analogues on cultured trabecular meshwork cells by coherent anti-stokes Raman scattering
P2860
Q26830201-1FB87A11-D680-454A-9777-010B0BEAB4B7Q26991731-880906A0-27A2-4A68-9B6E-8F8962F7FA27Q27024271-4708DC92-925F-4DE7-A3E1-15772E17BCA8Q28077208-92963923-61D1-4768-A2AB-6162161848D8Q28548224-05C76075-9504-40D6-A696-185625AC35DAQ30472509-306B37BF-3648-469C-AAE6-713585F3023DQ30534775-F9C26AE5-3805-4C32-8955-67797C9091F8Q33687798-5FC11705-9A29-4913-BCA3-69FDBDC7BEB3Q33727601-D2F3EDC2-4DB0-4E7F-802D-A87541E3F981Q33857744-459CED72-2E4B-4CD4-8871-D4E259779017Q34043309-C534E855-8E00-47A6-87E9-290771A944A0Q34177887-BB2C26B2-5B64-414E-B200-4EF6CEB6297FQ34255437-D05ADA66-DF92-4818-A39B-493009EBD2F2Q34274254-59798F1F-C192-4D03-9A93-CB6095874F74Q34284681-22EE700F-CFDF-4450-B4E9-7E13FA67AB3EQ34335584-E590DF71-492A-41F3-9440-E1241291E4EDQ34393424-E090A497-8325-49DC-BCFE-9E472DF59ABCQ34511234-393C7721-F62B-457D-925A-E730BE613417Q34570414-A018E107-9769-4A4D-B65D-56CDB3FA6D5CQ34708267-929EC61F-499A-4624-AE62-0A8EFE8FF9A8Q34708308-7C6028D5-BAB5-43AD-B144-769ACC40EBBAQ34730252-7E2B7D4E-EB99-437B-A0C1-60366EEC1A9CQ34731426-B066452C-0EF8-434B-8220-3F69FB1DCA3EQ35079342-8B8B4A17-1939-4005-BFEF-EB2AF0412ACBQ35175058-E012003B-1085-46B5-9B83-1F53EEB19BEEQ35220605-2D20EAF4-210E-4C6F-AB90-59F8B3AC8AC3Q35221250-6E167378-64A0-4B98-95AE-D8FC02F65F0FQ35617544-090EEF7D-F404-4CDA-B328-6A4DFFCC6A49Q35681331-9ABB7EA3-646F-4EED-8134-3FD52D3A1447Q35812926-AC3810EC-A703-4C27-BE8D-6816480D0AEFQ35949978-4B0993D4-0B19-41FB-8ED9-CB49ACB43E3BQ35969296-2D11A9BA-B4E5-45C2-8BA4-94169B95F1BCQ36044733-31037C1E-E505-405E-B29C-09A91AA033BDQ36157157-EC1431D4-FD84-452D-887F-5E41405C11FAQ36192495-AE2F5716-2D83-4242-83F6-A303CC9644FDQ36495854-50D98D4B-52A8-40DC-9FF5-A97B2D57CE38Q36586496-337E1898-4546-43BB-A966-FFDA15AC77B8Q36807917-759EF998-6AA6-4A69-A763-5A9C77447886Q36908446-0E07DDAB-EE7E-4035-836E-B5A9E708447EQ37145625-8FF3DB7B-5FF0-42E4-9A9D-CC6D885790A9
P2860
Update on the mechanism of action of topical prostaglandins for intraocular pressure reduction.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Update on the mechanism of act ...... ntraocular pressure reduction.
@en
Update on the mechanism of act ...... ntraocular pressure reduction.
@nl
type
label
Update on the mechanism of act ...... ntraocular pressure reduction.
@en
Update on the mechanism of act ...... ntraocular pressure reduction.
@nl
prefLabel
Update on the mechanism of act ...... ntraocular pressure reduction.
@en
Update on the mechanism of act ...... ntraocular pressure reduction.
@nl
P2093
P2860
P1476
Update on the mechanism of act ...... ntraocular pressure reduction.
@en
P2093
B'Ann T Gabelt
Carol B Toris
Paul L Kaufman
P2860
P304
P356
10.1016/J.SURVOPHTHAL.2008.08.010
P478
P577
2008-11-01T00:00:00Z